⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Association of Vitamin B12 and Homocysteine with Parkinson’s Disease Progression in Contemporary Trials (P9-3.013)

Chadwick W. Christine Peggy Auinger Esther Forti Lyvin Tat Noemi Cannizzaro David Oakes Ralph Green

View Full Paper

Ask AI

Bookmark

Share

Abstract

To measure blood levels of vitamin B12 and homocysteine (tHcy) in contemporary clinical trial cohorts and to correlate with Parkinson's disease (PD) progression.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Christine et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdb8b6db64358767831f https://doi.org/10.1212/wnl.0000000000204400

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials2024 · 4 citations
2The Impact of the Dietary Intake of Vitamin B12, Folic Acid, and Vitamin D3 on Homocysteine Levels and the Health-Related Quality of Life of Levodopa-Treated Patients with Parkinson’s Disease—A Pilot Study in Romania2024 · 7 citations
3The effect of serum homocysteine, vitamin B12, and folate levels on cognition in Parkinson\'s disease and Parkinson\'s disease dementia2025
4Comparison of plasma homocysteine levels and frequency of polyneuropathy in idiopathic Parkinsonian patients with healthy controls2025
5Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric StudyOriginal Research · 2026